Code · BILL · 117th Congress · S. 4535 (Introduced in Senate) — To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs,... · Sec. 406

Sec. 406. Effective date

78 words·~1 min read·/bill/117/s/4535/is/section-406

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

The amendments made by this title shall take effect on October 1, 2022, or the date of the enactment of this Act, whichever is later, except that fees under part 8 of subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–51 et seq. ) shall be assessed for all biosimilar biological product applications received on or after October 1, 2022, regardless of the date of the enactment of this Act.

Connections1 off-index

1 reference not yet in our index

21 USC 379j–51

Citation graph

cites case law

Sec. 406

Effective date

Cite21 USC 379j–51

Cites 1Cited by 0 across 0 sources